ID   OCUM-2M/OXA
AC   CVCL_IV69
DR   Wikidata; Q54931829
RX   PubMed=20393015;
RX   PubMed=27157913;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C9159; Gastric diffuse adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8383 ! OCUM-2M
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 8
//
RX   PubMed=20393015;
RA   Zhang X.-T., Yashiro M., Qiu H., Nishii T., Matsuzaki T., Hirakawa K.;
RT   "Establishment and characterization of multidrug-resistant gastric
RT   cancer cell lines.";
RL   Anticancer Res. 30:915-921(2010).
//
RX   PubMed=27157913; DOI=10.1016/j.canlet.2016.05.002;
RA   Takahashi K., Tanaka M., Yashiro M., Matsumoto M., Ohtsuka A.,
RA   Nakayama K.-i., Izumi Y., Nagayama K., Miura K., Iwao H., Shiota M.;
RT   "Protection of stromal cell-derived factor 2 by heat shock protein 72
RT   prevents oxaliplatin-induced cell death in oxaliplatin-resistant human
RT   gastric cancer cells.";
RL   Cancer Lett. 378:8-15(2016).
//